LD-2 disclosure · 3rd Quarter - Amendment
BIOGEN IDEC
Client
- Name
- BIOGEN IDEC
- Description
- Biotechnology company that develops biopharmaceutical therapies
- Location
- District of Columbia · United States of America
Registrant
- Description
- Lobbying Law Firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
4 issuesHealth Issues
General education about policies impacting pharmaceutical development, approval, and reimbursement; H.R. 1628, American Health Care Act of 2017.
LobbyistsKARINA LYNCH · ANDREW JONES · CHERYL LYNN JAEGER
Covered position (ANDREW JONES): Legislative Counsel, Rep Hinojosa; Legislative Director and Counsel, Rep. Lujan
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)
Medicare/Medicaid
General education about policies impacting pharmaceutical development, approval, and reimbursement, including Medicare payment policies.
LobbyistsKARINA LYNCH · ANDREW JONES · CHERYL LYNN JAEGER
Covered position (ANDREW JONES): Legislative Counsel, Rep. Hinojosa; Legislative Director and Counsel, Rep. Lujan
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)
Budget/Appropriations
Education about policies to improve newborn screening programs.
LobbyistsCHERYL LYNN JAEGER